A prospective validation of the genomic classifier to define high-metastasis risk in a subset of African American men with early localized prostate cancer: VanDAAM study.

Kosj Yamoah,Jasreman Dhillon,Peter A.S. Johnstone,Julio M. Pow-Sang,Elai Davicioni,Angelina K. Fink,Amanda C DeRenzis,G. Daniel Grass,Roger Li,Brandon Manley,Kenneth L. Gage,Evangelia Katsoulakis,Ryan J Burri,Andrew Leone,Cesar E. Ercole,Joshua D. Palmer,Neha Vapiwala,Curtiland Deville,Timothy R. Rebbeck,Adam P. Dicker

A prospective validation of the genomic classifier to define high-metastasis risk in a subset of African American men with early localized prostate cancer: VanDAAM study.

2021

5005Background: Risk stratification of prostate cancer (PC) using routine clinical variables remains suboptimal as they do not account for underlying tumor biology. The genomic classifier provides ...

Keywords:

clinical variables
tumor biology
Oncology
Internal medicine
Medicine
risk stratification
Classifier (UML)
Metastasis
Prostate cancer
african american men

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations